Drug delivery vehicles' shape could determine efficacy
A group of researchers at the University of Pennsylvania say that string-like nanoparticles survive longer than spherically shaped nanoparticles, which leads them to believe that the right shape is a key concern in designing new delivery vehicles for drugs. Dennis Discher and colleagues at the University of Pennsylvania say that string-like nanoparticles circulated for up to a week in rodents, significantly longer than the carbon nanotubes that have been studied in depth. Their work appears in the April issue of the journal Nature Nanotechnology.
- read the UPI's report on drug delivery vehicles
Related Articles:
Nanotech grows more common in drug dev research. Report
FDA to gather more info on bio-nano. Report
Nanoparticle programs advance the science of small. Report
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


